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Scalp-ear-nipple (SEN) syndrome is a rare, autosomal-dominant disorder characterized by cutis aplasia of the scalp; minor anomalies of
the external ears, digits, and nails; and malformations of the breast. We used linkage analysis and exome sequencing of a multiplex
family affected by SEN syndrome to identify potassium-channel tetramerization-domain-containing 1 (KCTD1) mutations that cause
SEN syndrome. Evaluation of a total of ten families affected by SEN syndrome revealed KCTD1missensemutations in each family tested.
All of the mutations occurred in a KCTD1 region encoding a highly conserved bric-a-brac, tram track, and broad complex (BTB) domain
that is required for transcriptional repressor activity. KCTD1 inhibits the transactivation of the transcription factor AP-2a (TFAP2A) via its
BTB domain, andmutations in TFAP2A cause cutis aplasia in individuals with branchiooculofacial syndrome (BOFS), suggesting a poten-
tial overlap in the pathogenesis of SEN syndrome and BOFS. The identification of KCTD1mutations in SEN syndrome reveals a role for
this BTB-domain-containing transcriptional repressor during ectodermal development.Scalp-Ear-Nipple (SEN) syndrome (MIM 181270), or Fin-
lay-Marks syndrome, is a rare autosomal-dominant
disorder first described in 1978 by Finlay and Marks,1
and to date, fewer than 15 independent cases have been re-
ported.2–12 SEN syndrome is characterized by aplasia cutis
congenita (ACC) of the scalp, breast abnormalities that
range from hypothelia or athelia to amastia, and minor
anomalies of the external ears (Figure 1). Less frequent
clinical characteristics include nail dystrophy, dental
anomalies, cutaneous syndactyly of the digits, and renal
malformations. The penetrance of SEN syndrome appears
to be high, although it exhibits substantial variable expres-
sivity within families. The phenotypic features of SEN
syndrome overlap with those of several syndromes,
perhaps most notably ulnar-mammary syndrome (MIM
181450) and ectrodactyly with ectodermal dysplasia and
cleft lip/palate syndrome (MIM 129900). Nevertheless,
despite screening of candidate genes (e.g., TBX3 [MIM
601621] and TP63 [MIM 603273]) in which mutations
cause syndromes with similar phenotypic characteristics
(data not shown), the genetic basis of SEN syndrome
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The AmTo identify causative mutations for SEN syndrome, we
performed a genome-wide linkage scan under a dominant
model (f1¼ 1; q¼ 0.0001) by using short tandem repeats in
the ABI PRISM Linkage Mapping Set Version 2.5 MD10 on
a large pedigree with 15 affected individuals spanning four
generations previously reported by Edwards et al. (family A
in Figure 2; Table 1 and Table S1, available online). This
linkage-mapping set used 382 autosomal and 18 X-linked
microsatellite markers to define an approximately 10 cM
resolution human index map. A pairwise maximum LOD
score (Zmax) of 2.94 was obtained with the marker
D18S53 at a recombination fraction (Q) of 0.001 (no other
linkage peaks were found; Table S2). Haplotype analysis
defined a ~42.9 Mb critical interval containing ~206 genes
between D18S452 and D18S474. Without an obvious
candidate gene within this interval to test, we next per-
formed exome sequencing of the two most distantly
related affected individuals in family A (Figure 2) and of
the affected individuals from two additional unrelated
families (families B and C in Figure 2). All studies were
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Figure 1. Characteristic Physical Find-
ings in Individuals with SEN Syndrome
Clinical characteristics of SEN syndrome
include cutis aplasia of the vertex of the
scalp (A, B, and D), minor external ear
defects, such as overfolded helix and
anteverted ears (C and F), and aplasia of
the nipples and sparse or absent secondary
sexual hair (G and H). Less common find-
ings include syndactyly and nail dysplasia
(E) and craniofacial malformations such
as telecanthus, a broad, flat nasal bridge,
and frontal bossing (F). Case identifiers
E:III-1 (A–C), F:II-1 (F), J:I-1 (D and H),
and J:II-1 (E and G) correspond to those
in Table 1 and Table S1, where a detailed
description of the phenotype of each
affected individual is provided.informed consent was obtained from participants or their
parents.
In brief, 1 mg of genomic DNAwas subjected to a series of
shotgun library construction steps, including fragmenta-
tion through acoustic sonication (Covaris), end polishing
(NEBNext End Repair Module), A tailing (NEBNext dA-
Tailing Module), and ligation of 8 bp barcoded sequencing
adaptors (Enzymatics Ultrapure T4 Ligase). Prior to exome
capture, the library was amplified via PCR (BioRad iProof).
One microgram of barcoded shotgun library was hybrid-
ized for the capture of probes targeting 64 Mb of coding
exons and miRNA (Roche Nimblegen SeqCap EZ Human
Exome Library v.3.0) per the manufacturer’s protocol,
and custom blockers complimentary to the full length of
the flanking adaptor and barcodes were added. Enriched
libraries were amplified via PCR before sequencing (BioRad
iProof). Library quality was determined by the examina-
tion of molecular-weight distribution and sample concen-
tration (Agilent Bioanalyzer). Pooled, barcoded libraries
were sequenced via paired-end 50 bp reads with an 8 bp
barcode read on Illumina HiSeq sequencers.
Demultiplexed BAM files were aligned to a human refer-
ence (UCSC Genome Browser hg19) with the Burrows-622 The American Journal of Human Genetics 92, 621–626, April 4, 2013Wheeler Aligner.13 Read data from
a flow-cell lane were treated indepen-
dently for alignment and quality-
control purposes in instances where
the merging of data from multiple
lanes was required. All aligned
read data were subjected to: (1)
removal of duplicate reads (Picard),
(2) indel realignment with the GATK
IndelRealigner, and (3) base-
quality recalibration with GATK
TableRecalibration. Variant detection
and genotyping were performed with
the UnifiedGenotyper tool from
GATK (refv.1.529). Variant data for
each sample were formatted (in
variant call format [VCF]) as ‘‘raw’’calls that contained individual genotype data for one or
multiple samples. Low-quality and potentially false-posi-
tive sites (e.g., those with quality scores% 50, allelic imbal-
ance R 0.75, long homopolymer runs [>3], and/or low
quality by depth [<5]) were flagged with the filtration
walker (GATK). Variant data were annotated with the Seat-
tleSeq Annotation Server.
The region under the linkage peak was examined for rare
and/or unique functional variation, including indels and
missense, nonsense, and splice-site mutations, shared
among affected individuals in family A. Variants found in
dbSNP v.134 or in ~1,530 exomes from a subset of the
National Heart, Lung, and Blood Institute (NHLBI) Exome
Sequencing Project (ESP) were excluded prior to analysis
for all sequenced individuals. This approach identified two
genes, KCTD1 (MIM 613420) and EPG5, with candidate
missense variants. In the exome data from the two addi-
tional unrelated affected individuals with SEN syndrome,
nocandidate variantswere identified inEPG5, but each indi-
vidualhadadifferentmissensemutationinKCTD1 (Figure3,
Table 1, andTable S1). The presence of each variant found in
KCTD1 (RefSeq accession number NM_001258221.1) was
subsequently confirmed by Sanger sequencing.
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Figure 2. Pedigrees of Families A–J
Pedigrees illustrating the relationships and
affected status of ten families affected by
SEN syndrome. Case identifiers correspond
to those in Table 1 and Table S1. Grey dots
indicate individuals who underwent
exome sequencing. Plus signs (þ) indicate
individuals in whommutations were iden-
tified, andminus signs (–) indicate individ-
uals in whom no mutation was found.
Family A individuals with a plus or minus
sign (except individuals IV-14 and V-6)
were also included in the linkage analysis.To determine the extent to which KCTD1 mutations
explain cases of SEN syndrome, we used Sanger sequencing
to screen seven additional unrelated families (Figure 2)
with a total of nine affected individuals available for
sequencing. We identified missense mutations in KCTD1
in all seven families (Figure 3, Table 1, and Table S1).
Collectively, between the three families used for discovery
and the seven families used for validation studies, KCTD1
mutations were found in all ten kindreds tested. Accord-
ingly, there is no evidence that SEN syndrome is geneti-
cally heterogeneous.
In total, ten unique missense KCTD1 mutations were
identified in either exon two (n ¼ 7) or exon three
(n ¼ 3) of KCTD1 (Figure 3, Table 1, and Table S1). None
of the KCTD1 missense mutations identified in the
subjects were found in >13,000 chromosomes sequenced
as part of the NHLBI ESP. The clinical characteristics of
individuals with different KCTD1 mutations were similar
to one another (Table 1 and Table S1), despite the variable
expressivity of SEN syndrome within families. Addition-
ally, no heterozygous pathogenic KCTD1 variants were
found in six tested families affected by dominantly in-
herited isolated ACC (MIM 107600).
KCTD1 is a member of a family of proteins that contain
a potassium-channel tetramerization domain (KCTD).14,15
The amino acid sequence of KCTD1 is highly conserved,
and humans and mice differ only by an 8 aa insertion
immediately following the start codon; humans and rats
differ only by a single amino acid residue.14 TheThe American Journal of HumaN-terminal KCTD (T1) of KCTD1
overlaps with a bric-a-brac, tram
track, and broad complex (BTB)
domain (T1-type BTB domain), which
is commonly found in transcriptional
regulators that contain zinc-finger
motifs and that mediate protein-
protein interactions.16 The BTB
domain of KCTD1 has been shown
to mediate the transcriptional
repressor activity of KCTD1 and to
be required for the homomerization
of KCTD1 proteins.14 Thus, alter-
ations within the BTB domain ofKCTD1 would be predicted to affect its transcriptional
repressor activity.
From Drosophila to humans, highly conserved BTB
domains are involved in dimerization, transcriptional
repression, and nuclear localization. Crystollographic
analysis of the BTB domain in human promyelocytic
leukemia zinc finger (PLZF) identified a charged pocket
formed by the apposition of two BTB monomers.17 Proper
alignment of charge within this pocket is essential for BTB
to act as a transcriptional repressor because altering the
charge of critical residues (Asp35 and Arg49 in PLZF) in
the BTB pocket results in partial or complete loss of
repressor activity.
All of the KCTDmutations that cause SEN syndrome are
missense mutations predicted to alter BTB-domain resi-
dues, including several residues that form the BTB pocket
or that are adjacent to such residues. Specifically, in the
crystal structure of the PLZF BTB domain, the floor of the
pocket is formed by residues 33–35 whereas each wall is
formed by residues 63, 64, and 66–68.17 Accordingly, we
predict that KCTD1 mutations that cause SEN syndrome
are likely to affect the transcriptional repressor activity of
the BTB domain. Clustering of missense mutations within
a structural hotspot and the absence of stops, frameshifts,
and splice-site mutations could mean that the missense
mutations we have identified cause loss of function via
a dominant-negative mechanism. This would be consis-
tent with the observation that KCTD1 forms homodimers
and that some alterations of the PLZF pocket reducen Genetics 92, 621–626, April 4, 2013 623
Table 1. Mutations and Clinical Findings of Individuals with SEN Syndrome
Case Reference Ancestry Gender
Mutation Information Clinical Findings
KCTD1
Exon
Nucleotide
Change
GERP
Score
Amino
Acid
Change
Predicted
Effect
Cutis
Aplasia
Ear
Anomaly
Absent or
Hypoplastic
Nipples
and/or
Breast
Family A
II-8 Edwards et al.4 European male 2 c.89C>A 5.68 p.Ala30Glu missense þ þ þ
III-4 Edwards et al.4 European male 2 c.89C>A 5.68 p.Ala30Glu missense þ þ þ
III-7 Edwards et al.4 European female 2 c.89C>A 5.68 p.Ala30Glu missense þ þ þ
III-8 Edwards et al.4 European male NT NT NT NT NT þ þ 
IV-5 Edwards et al.4 European female 2 c.89C>A 5.68 p.Ala30Glu missense þ þ 
IV-6 Edwards et al.4 European female 2 c.89C>A 5.68 p.Ala30Glu missense þ þ 
IV-8 Edwards et al.4 European male 2 c.89C>A 5.68 p.Ala30Glu missense þ þ þ
IV-10 Edwards et al.4 European female 2 c.89C>A 5.68 p.Ala30Glu missense þ þ þ
IV-11 Edwards et al.4 European male 2 c.89C>A 5.68 p.Ala30Glu missense þ þ þ
V-1 Edwards et al.4 European male 2 c.89C>A 5.68 p.Ala30Glu missense þ ND ND
V-3 Edwards et al.4 European female 2 c.89C>A 5.68 p.Ala30Glu missense þ þ þ
V-4 Edwards et al.4 European female NT NT NT NT NT þ þ þ
V-5 Edwards et al.4 European male 2 c.89C>A 5.68 p.Ala30Glu missense þ ND ND
V-6 Edwards et al.4 European female 2 c.89C>A 5.68 p.Ala30Glu missense þ þ þ
Family B
II-2 NA European female 2 c.92C>T 5.68 p.Pro31Leu missense þ þ þ
III-1 NA European male 2 c.92C>T 5.68 p.Pro31Leu missense þ þ þ
III-4 NA European female NT NT NT NT NT þ þ þ
Family C
II-2 NA European female 2 c.58C>T 5.68 p.Pro20Ser missense þ þ þ
III-1 NA European male 2 c.58C>T 5.68 p.Pro20Ser missense þ þ þ
Family D
II-1 Sobreira et al.9 Brazilian male 2 c.99C>A 5.68 p.His33Gln missense þ þ þ
Family E
II-1 NA European female 2 c.98A>C 5.68 p.His33Pro missense þ þ þ
III-1 NA European female 2 c.98A>C 5.68 p.His33Pro missense þ þ 
Family F
II-1 NA European female 3 c.207C>A 5.78 p.Asp69Glu missense þ þ þ
Family G
II-1 Le Merrer et al.12 North African female 2 c.92C>G 5.68 p.Pro31Arg missense þ þ þ
Family H
II-1 Plessis et al.8 European female 3 c.221A>C 5.78 p.His74Pro missense þ þ þ
Family I
I-1 Picard et al.7 European male NT NT NT NT NT þ þ þ
II-1 Picard et al.7 European female 3 c.185G>A 5.63 p.Gly62Asp missense þ  
(Continued on next page)
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Table 1. Continued
Case Reference Ancestry Gender
Mutation Information Clinical Findings
KCTD1
Exon
Nucleotide
Change
GERP
Score
Amino
Acid
Change
Predicted
Effect
Cutis
Aplasia
Ear
Anomaly
Absent or
Hypoplastic
Nipples
and/or
Breast
Family J
I-1 NA Brazilian male 2 c.92C>A 5.68 p.Pro31His missense þ  þ
II-1 NA Brazilian male 2 c.92C>A 5.68 p.Pro31His missense þ þ þ
This table depicts mutation information and associated clinical findings for individuals with SEN syndrome. Plus signs (þ) indicate the presence of a finding, and
minus signs (–) indicate the absence of a finding. GERP scores provide an estimate of conservation across species at a nucleotide site; a more positive score is asso-
ciated with deleteriousness. An expanded phenotype table is provided in Table S1. The following abbreviations are used: GERP, Genomic Evolutionary Rate
Profiling; ND, no data; NA, not applicable; and NT, not tested.transcriptional repression even though they do not disrupt
dimerization. It remains to be determined whether substi-
tutions of amino acids not directly contributing to the
functional integrity of the BTB also cause SEN syndrome
by disrupting transcriptional repression.
One protein family with which KCTD1 interacts is the
AP-2a family of transcription factors. Specifically, KCTD1
interacts with TFAP2A, TFAP2B, and TFAP2C via its BTB
domain and acts as a strong repressor of TFAP2A transcrip-
tional activity.15 This is noteworthy because mutations in
TFAP2A cause branchiooculofacial syndrome (BOFS [MIM
113620]), one of the features of which is branchial cutis
aplasia.18 This observation suggests that the cutis aplasia
observed in SEN syndrome might result from altered regu-
lation of TFAP2A. Thus, the identified mutations within
the region encoding the BTB domain of KCTD1 in SEN
syndrome might affect its inhibitory activity on AP-2aThe Amtransactivation during embryogenesis and result in devel-
opmental defects in skin formation. It is likely that the
additional ectodermal abnormalities affecting the ears
and nipples in SEN syndrome are a consequence of altered
repressor activity of the KCTD1 BTB domain on other tran-
scription factors involved in the formation of these ecto-
dermally derived anatomic structures. This is not
surprising given that proteins with a BTB domain have
been shown to have multiple roles during embryogenesis
and tissue homeostasis, including skin structure.19
In summary, we used linkage analysis and exome
sequencing to discover that missense mutations in
KCTD1 explain the cause of SEN syndrome in all ten fami-
lies that we tested. Mutations in KCTD1 were clustered in
the region that encodes a functional pocket of its BTB
domain, the perturbation of which in other BTB-contain-
ing proteins causes loss of disruption of transcriptionalFigure 3. Genomic Structure and Allelic
Spectrum of KCTD1Mutations that Cause
SEN Syndrome
KCTD1 is composed of five exons that
encode UTRs (orange) and protein-
coding-sequence domains (blue),
including a BTB domain (red). Arrows indi-
cate the locations of ten different muta-
tions found in ten families affected by
SEN syndrome. Carrots indicate mutations
that were confirmed to be de novo.
Deduced amino acid sequences of partial
KCTD1 in multiple species are shown.
Locations of amino acid residues affected
by KCTD1 mutations are shaded.
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activity. The findings reveal a function of the KCTD1 BTB
domain during ectodermal development. Our findings
also indicate that phenotypic overlap between SEN
syndrome and BOFS might be due to a shared defect in
the same biological process and suggest that similar clinical
cases for which the gene has yet to be discovered might be
due to variants in genes that have a similar role.Supplemental Data
Supplemental Data include two tables and can be found with this
article online at http://www.cell.com/AJHG.Acknowledgments
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